Tajikistan reported over 8,000 TB cases in 2023, with nearly 4,000 people still missing from care. The burden of drug-resistant TB continues to grow, with more than 2,200 estimated DR-TB cases and 1,728 still undiagnosed. Around 250 people were coinfected with both TB and HIV, a 20% increase from the year prior. While the country has made modest gains in case detection, diagnostic coverage in remote and underserved areas remains limited.
To support national screening and diagnostic efforts, we began working in Tajikistan in 2021, delivering three Delft Light portable X-ray systems, each equipped with CAD4TB, to the Republic Centre for Protection of the Population from TB. The project was facilitated through the Global Drug Facility (GDF).
In 2022, we partnered with Medecines Sans Frontieres (MSF) to deploy multiple CAD4TB solutions and deliver user training and capacity building in-country. Later that year, the collaboration expanded with the delivery of a Delft Light portable X-ray system and accompanying support services to strengthen TB screening and triage across remote regions.
The expansion continued in 2024. With support from MSF, we delivered 18 Delft Light systems and 18 CAD4TB units along with installation, service and training. That same year, 2 additional Delft Light systems with CAD4TB were deployed through a UNOPS-led project. These efforts are helping to close diagnostic gaps and bring timely care to the communities that need it most.
Making a Difference
Webinar insights
For more information on how the Delft Light portable X-ray systems and the CAD4TB have been used in Tajikistan, please view the story on ‘The Practical Application of Portable Digital X-ray Systems in Tuberculosis Service of the Republic of Tajikistan’, as presented by Dr Nurov Rustam Madjidovich. The story was presented during the 2022 Delft webinar.
